Corvus Pharmaceuticals's chart data is dated 2026-10-09. Recorded technical signals: RSI rebound. There are 0 published signal records.
Corvus Pharmaceuticals last closed at $10.52 (+3.04%) on 2026-10-09. Signals today: RSI rebound. Listed on Nasdaq. Trailing 12 months PER is -17.4×. Its overall grade ranks 225 of 738 stocks in Healthcare.
About this company
Corvus Pharmaceuticals last closed at $10.52 (+3.04%) on 2026-10-09. Signals today: RSI rebound. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 225/738
Valuation grade A+
Related stocks
- AstraZenecaCompetitor
면역항암제·종양/염증 치료제 개발 영역에서 경쟁
- Merck & Co.Competitor
면역항암 및 항암제 시장의 대형 경쟁사
- Bristol Myers SquibbCompetitor
면역항암·항암 파이프라인 경쟁사
About Corvus Pharmaceuticals
- What technical signals does Corvus Pharmaceuticals (CRVS) have?
- Corvus Pharmaceuticals current technical signals: RSI rebound.
- Is Corvus Pharmaceuticals a cup-and-handle pattern?
- No. Corvus Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Corvus Pharmaceuticals?
- Market cap: $785.65M. Trailing 12 months PER: -17.4×. Latest quarter PBR: 4.19×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Corvus Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.